EcoDrugPlus

Carbonic Anhydrase 12

Ensembl ID : ENSMLUG00000007452
Gene Symbol: CA12
2 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 13

Ensembl ID : ENSMLUG00000006164
Gene Symbol: CA13
2 Cross references
288 Possible Orthologues:

Carbonic Anhydrase 14

Ensembl ID : ENSMLUG00000013677
Gene Symbol: CA14
2 Cross references
210 Possible Orthologues:

Carbonic Anhydrase 2

Ensembl ID : ENSMLUG00000022410
Gene Symbol: CA2
2 Cross references
282 Possible Orthologues:

Carbonic Anhydrase 3

Ensembl ID : ENSMLUG00000016286
Gene Symbol: CA3
2 Cross references
307 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSMLUG00000013361
Gene Symbol: CA5A
2 Cross references
167 Possible Orthologues:

Carbonic Anhydrase 5b

Ensembl ID : ENSMLUG00000009760
Gene Symbol: CA5B
2 Cross references
222 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSMLUG00000001387
Gene Symbol: CA6
2 Cross references
218 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSMLUG00000012984
Gene Symbol: CA7
4 Cross references
220 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSMLUG00000011456
Gene Symbol: CA9
2 Cross references
280 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSMLUG00000011391
Gene Symbol: CSNK1E
2 Cross references
268 Possible Orthologues:

Caspase 8

Ensembl ID : ENSMLUG00000015535
Gene Symbol: CASP8
2 Cross references
132 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).